发明名称 |
ErbB3 binding antibody |
摘要 |
The present invention relates to an antibody, particularly a monoclonal antibody, which binds to the ErbB3 receptor, compositions comprising such an antibody as well as methods using such an antibody. |
申请公布号 |
US9346889(B2) |
申请公布日期 |
2016.05.24 |
申请号 |
US201113880114 |
申请日期 |
2011.09.12 |
申请人 |
MEDIAPHARMA S.R.L. |
发明人 |
Muraro Raffaella;Iacobelli Stefano;Tinari Nicola;Traini Sara;Sala Gianluca |
分类号 |
C12N5/10;C12N15/10;C12N15/11;C07K16/28;A61K39/395;C07K16/40;C07K16/32;A61K45/06;A61K39/00 |
主分类号 |
C12N5/10 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck, p.c. |
代理人 |
Rothwell, Figg, Ernst & Manbeck, p.c. |
主权项 |
1. An antibody or fragment thereof which binds to the ErbB3 receptor and which comprises:
(a) a heavy chain amino acid sequence encoded by SEQ ID NO: 1 or at least the variable domain thereof or an amino acid sequence having a sequence identity of at least 95% thereto, wherein the heavy chain amino acid sequence comprises complementarity determining regions CDR1, CDR2, and CDR3, wherein CDR1 comprises the amino acid residues 50-54 from SEQ ID NO:3, CDR2 comprises the amino acid residues 69-85 from SEQ ID NO:3, and CDR3 comprises the amino acid residues 118-130 from SEQ ID NO:3 and (b) a light chain amino acid sequence encoded by SEQ ID NO: 2 or at least the variable domain thereof or an amino acid sequence having a sequence identity of at least 95% thereto, wherein the light chain amino acid sequence comprises complementarity determining regions CDR1, CDR2, and CDR3, wherein CDR1 comprises the amino acid residues 46-60 from SEQ ID NO:13, CDR2 comprises the amino acid residues 76-82 from SEQ ID NO:13 and CDR3 comprises the amino acid residues 115-123 from SEQ ID NO:13. |
地址 |
Chieti IT |